From October 1, 2022 to December 31, 2022, the company has repurchased 540,000 shares, representing 0.1% for CNY 2.7 million. With this, the company has completed the repurchase of 7,198,500 shares, representing 1.28% for CNY 37.65 million under the buyback announced on July 15, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.58 CNY | -3.78% | -6.15% | -25.29% |
1st Jan change | Capi. | |
---|---|---|
-25.29% | 35Cr | |
+42.16% | 75TCr | |
+33.75% | 60TCr | |
-5.87% | 36TCr | |
+18.18% | 33TCr | |
+4.64% | 28TCr | |
+17.57% | 24TCr | |
+9.18% | 21TCr | |
-4.21% | 21TCr | |
+2.83% | 17TCr |
- Stock Market
- Equities
- 600222 Stock
- News Henan Taloph Pharmaceutical Stock Co.,Ltd
- Tranche Update on Henan Taloph Pharmaceutical Stock Co.,Ltd's Equity Buyback Plan announced on July 15, 2022.